Despite these limitations, our study showed that, as in several adult neurodegenerative disease, PIEZO1 DNAm alteration may serve as a potential epigenetic marker associated with early brain dysfunction, such as that observed in infants with NDs. Here, PIEZO1 is linked to neurodegenerative disease.